Hims & Hers vs. Novo Nordisk: Are Compounded GLP-1s Safe?
Following Hims & Hers’ Super Bowl ad for its weight loss product, a debate has emerged over the safety of ...
Tag: GLP1s
Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them ...
The Rapid Growth of GLP-1s and Their Impact on Bariatric Surgery
GLP-1 is expected to grow to a $71 billion industry by 2031. GLP-1 medications are fueled by the 66% of ...
ResMed CEO sees GLP-1s, wearables driving CPAP device demand
NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York ...
GLP-1s Can Improve Many Common Health Issues, but They’re Not Magic
GLP-1-based agonists (GLP-1s) are transforming the obesity treatment landscape and the positive results keep rolling in. In the last 12 ...
GLP-1s lower risk of 10 obesity-associated cancers, study shows
New analysis finds that the GLP-1 class of medicine — glucagon-like peptide receptor agonists — is simpler in mitigating the ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!